Apparatus having variable strut length and methods of use

Abstract
A tubular prosthesis has a plurality of tubular rings that are radially expandable from a contracted configuration to an expanded configuration. Each ring comprises a plurality of axially oriented struts that are interconnected so as to form a circumferential series of at least one high peak and at least one low peak. The high and low peaks have apices that are oriented in the same axial direction. The apices of the high and low peaks are also oriented in the same direction and the apices of the high peaks are axially offset from the apices of the low peaks. A bridge member couples a pair of adjacent tubular rings together. The bridge member has a first end connected to a first low peak in a first tubular ring and a second end connected to either a high or low peak in an adjacent tubular ring.
Description
CROSS-REFERENCES TO RELATED APPLICATIONS

Not Applicable


STATEMENT AS TO RIGHTS TO INVENTIONS MADE UNDER FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT

Not Applicable


REFERENCE TO A “SEQUENCE LISTING,” A TABLE, OR A COMPUTER PROGRAM LISTING APPENDIX SUBMITTED ON A COMPACT DISK

Not Applicable


BACKGROUND OF THE INVENTION

1. Field of Invention


The invention generally relates to medical apparatus and methods, and more specifically to prosthetic devices such as stents for use in the coronary and peripheral arteries as well as in other vessels and body lumens.


Stenting is an important treatment for patients with vascular occlusive disease. A stent is often a hollow, tubular implant designed to provide scaffolding to the walls of a diseased blood vessel or other body lumen in order to maintain patency of the vessel or lumen. Stents are usually placed at the site of a stenotic lesion within an artery after a primary treatment such as angioplasty. They are typically delivered to the arteries using long, flexible catheters inserted percutaneously through the patient's femoral artery.


Stents are typically either balloon expandable or self-expandable. Balloon expandable stents are mounted over a balloon or other expansion element on a delivery catheter. When the balloon is inflated, the balloon expands and correspondingly expands and deforms the stent to a desired diameter. The balloon can then be deflated and removed, leaving the stent in place.


A self-expanding stent is simply released from the delivery catheter so that it expands until it engages the vessel wall. Self-expanding stents are typically delivered to a treatment site while compressed or crimped within a constraining sheath. Retraction of the sheath removes the constraint and allows the stent to radially expand into engagement with the vessel wall.


Self-expanding stents may be made of materials having high elasticity or a shape memory alloy such as Nitinol, a nickel-titanium (NiTi) alloy. Resilient, self-expanding stents are often used in the peripheral vascular system and regions of the body closer to the body's surface because their resilience helps minimize damage or crushing caused by body movement or externally applied forces.


Self-expanding stents may also have certain advantages over balloon expandable stents in the treatment of arteries. Balloon expandable stents are often expanded to a constant diameter and do not conform well with an artery having variations in diameter due to vessel tortuosity or taper. Because of the potential mismatch between stent diameter and vessel diameter, there is a possibility for gaps to form between the outer stent surface and the inner vessel wall, and this can lead to thrombosis formation. Self-expanding stents expand until their outer surface is constrained by contact with the vessel wall and thus the use of a self-expanding stent may eliminate or reduce these gaps thereby reducing thrombosis formation.


Another trend in stenting is the use of longer stents for treatment of long diffuse lesions in the peripheral vessels. While this procedure is promising, some challenges still exist. For example, longer stents are often less flexible and therefore are harder to deliver and deploy in torturous vessels, and they can fracture or kink. Therefore, there is a need for longer stents with improved flexibility.


The flexibility of stents may be improved through the variation of the stent geometry. Current stents are typically articulated tubes consisting of a series of axially adjacent, tubular rings interconnected with one another by one or more bridges. Each tubular ring often consists of several repeating cells formed from axially oriented struts, each having the same length. The cells are often arranged to form a helical, zig-zag, diamond, rectangular, undulating, mesh, or other pattern. Using struts of the same length in a repeating cell pattern results in uniform stent compression and expansion thereby helping to ensure uniform loading of a stent with a delivery catheter as well as uniform scaffolding of the treatment site after the stent has been deployed. The tubular rings are often rigid, providing mechanical support to the vessel but little or no axial flexibility. Thus, axial flexibility of the stent may be adjusted by using bridges to connect adjacent tubular rings. While it is desirable to keep the tubular rings close together in order to provide maximum scaffolding to the vessel, it is also desirable to have a longer gap between the tubular rings so that a longer bridge may connect adjacent tubular rings for greater stent flexibility. Additionally, by bringing tubular rings closer together or interleaving segment ends, the overall stent column strength is increased along with the stent's ability to resist twisting. This allows the stent rings to be coupled together with fewer bridges, thereby also increasing stent flexibility. Stent column strength is important during retraction of a constraining sheath during stent deployment. Friction between the sheath and the tubular rings may twist them relative to one another or buckle the stent forcing the segments together, thereby causing binding or potentially interfering with proper stent deployment. Thus, it is desirable to provide an improved stent that provides improved flexibility without substantially diminishing scaffolding ability or column strength, as well as providing other structural advantages while avoiding some of the aforementioned challenges.


2. Description of the Background Art


Prior patents and publications describing various stent geometries and stent delivery systems include U.S. Pat. Nos. 5,421,955; 5,716,393; 6,022,374; 6,132,460; 6,264,688; 6,273,911; 6,334,871; 6,375,676; 6,464,720; 6,582,460; 6,918,928; U.S. Patent Publication No. 2003/0114919; International PCT Publication WO 2008/005111; and European Patent No. EP 1318765.


BRIEF SUMMARY OF THE INVENTION

The present invention provides prostheses and methods for use thereof. In a first aspect of the present invention, a tubular prosthesis comprises a plurality of tubular rings radially expandable from a contracted configuration to an expanded configuration. Each ring has a plurality of axially oriented struts interconnected so as to form a circumferential series of at least one high peak and at least one low peak. The high and low peaks have apices that are oriented in the same axial direction and the apices of the high peaks are also axially offset from the apices of the low peaks. A bridge member couples a pair of adjacent tubular rings together and the bridge member has a first end connected to a first low peak in a first tubular ring and a second end connected to either a high or low peak in an adjacent tubular ring.


In another aspect of the present invention, a tubular prosthesis comprises a plurality of tubular rings radially expandable from a contracted configuration to an expanded configuration. Each ring comprises a plurality of axially oriented struts interconnected so as to form a circumferential series of high peaks and low peaks, the high and low peaks having apices oriented in the same axial direction and the apices of the high peaks are axially offset from the apices of the low peaks. Adjacent tubular rings interleave with one another such that a high peak on a first tubular ring nests between two high peaks on an adjacent tubular ring. A bridge member couples a pair of adjacent tubular rings together and the bridge member has a first end connected to the first tubular ring and a second end connected to the adjacent tubular ring.


In yet another aspect of the present invention, a method for delivering a prosthesis to a treatment site in a body comprises advancing a delivery catheter to the treatment site. The delivery catheter has a tubular prosthesis disposed thereon and the tubular prosthesis comprises a plurality of tubular rings with each ring having a plurality of axially oriented struts interconnected so as to form a circumferential series of at last one high peak and at least one low peak. The apex of the at least one high peak is axially offset from the apex of the at least one low peak. The method also includes selecting a first number of the tubular rings for deployment and radially expanding the first number of tubular rings into engagement with tissue at the treatment site. The delivery catheter may be repositioned to a second treatment site and then a second number of the tubular rings may be selected for deployment. The second number of rings is radially expanded so that they engage with tissue at the second treatment site without removing the delivery catheter from the body.


Advancing the delivery catheter may include intravascularly positioning the catheter in a blood vessel which may be an artery in a leg. Sometimes the plurality of tubular rings are self-expanding and radially expanding the first number comprises removing a constraint from the first number and/or the second number of tubular rings. The method may also include releasing a therapeutic agent carried by the tubular prosthesis at a controlled rate, such as an agent that inhibits restenosis. The first number may be greater than or equal to two and the second number may be different than the first number.


The apices of the high and low peaks in the first tubular ring may be circumferentially offset from the apices of the high and low peaks in the adjacent tubular ring. The apices of the low peaks in the first tubular ring may be circumferentially aligned with the apices of the high or low peaks in the adjacent tubular ring. The apices of the high and low peaks of the first tubular ring may point toward the apices of the high and low peaks of the adjacent tubular ring. The high and low peaks may be circumferentially alternative with one another in a tubular ring or they may be arranged circumferentially such that each high peak is disposed between two low peaks or one low peak and one high peak. Each high and low peak may be separated from an adjacent high or low peak by a valley, and the high peaks on the first tubular ring may be nested between valleys on the adjacent tubular ring. The circumferential width of each valley in the contracted configuration may be less than the circumferential width of each peak in the contracted configuration. The first low peak may be circumferentially offset from the high or the low peak in the adjacent tubular ring.


The plurality of axially oriented struts may comprise long struts and short struts with the short struts being shorter than the long struts and the plurality of axially oriented struts may be arranged circumferentially such that each short strut is disposed between one long strut and one short strut. Each high peak may comprise a long strut having a first length and each low peak may comprise a short strut having a second length shorter than the first length. Each low peak may comprise two short struts and each high peak may comprise one long strut and one short strut with the short strut being shorter than the long strut.


Various embodiments of bridge members are disclosed including bridge members having a shape selected from the group consisting of z, u, and s-shaped as well as sigmoidal shaped. Sometimes the bridge member may have a surface defining one or more apertures therein and sometimes the apertures may extend entirely through the bridge member. The apertures may have an axis that is substantially parallel to an outer surface of the prosthesis and sometimes the apertures may form an elongate slot. The bridge member has a thickness in the radial direction and sometimes that thickness may vary across the bridge member. The bridge member may have a first thickness and the plurality of axially oriented struts may have a second thickness greater than or different than the first thickness. The first thickness may be less than the second thickness. Some bridge members may comprise a spring element, a strain relief region or a resilient elastomer. Sometimes the bridge member may be slidably engaged with the connector.


The bridge member may comprise a transverse portion and a first axially oriented portion with the transverse portion transverse to the first axially oriented portion and coupled thereto. The bridge member may also further comprise a second axially oriented portion with the transverse portion disposed between the first and second axially oriented portions. The bridge member may have an axial length between the first and second ends that is longer than the axial distance between high peaks on adjacent tubular rings, or the axial length may be longer than the axial distance between a high peak and a low peak on adjacent tubular rings. The first end may be connected to either a high or low peak in the first tubular ring and the second end may be connected to either a second high or low peak in the adjacent tubular ring. The first end of the bridge member may connect to either the apex of the peak or a portion of the peak offset from the peak's apex. The second end of the bridge member may also connect to a portion of a peak offset from the apex in the adjacent tubular ring.


The tubular prosthesis may have a first ring disposed between the adjacent tubular ring and a third tubular ring with the first tubular ring connected to the third tubular ring by a second bridge member. The bridge member may have a first orientation and the second bridge member may have a second orientation that is a mirror image thereof, or the bridge member may have a first slope and the second bridge member may have a second slope that is opposite of the first.


The first end of the bridge member may connect to the first low peak at its apex. The second end of the bridge member may connect to the apex of either a high or low peak in the adjacent tubular ring. The bridge member may comprise a transverse portion that is transversely oriented to a longitudinal axis of the tubular prosthesis. The transverse portion may be disposed between a first peak on the first tubular ring and a second peak on the adjacent tubular ring thereby preventing the first peak from overlapping with the second peak when the tubular prosthesis is in compression. The transverse portion may have a length greater than a circumferential distance between the first and second peaks. The bridge member may also comprise an axial portion and a circumferential portion that is substantially transverse thereto. The bridge member may have a width that is substantially equivalent to a width of the axial struts. The bridge member may also comprise a first axially oriented region which includes the first end and a second axially oriented region which includes the second end.


The tubular prosthesis may be self-expanding and may have a length in the range from about 2 mm to about 200 mm. Sometimes, each of the plurality of tubular rings may have substantially the same axial length or they may be different. The prosthesis may comprise a third tubular ring adjacent the first tubular ring but that is not connected thereto. The prosthesis may further comprise a fourth tubular ring that is unconnected to but deployable with the first or third tubular ring. The prosthesis may carry a therapeutic agent that can be released from the prosthesis at a controlled rate and that agent may inhibit restenosis.


These and other embodiments are described in further detail in the following description related to the appended drawing figures.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1A is an unrolled view of an unexpanded stent.



FIG. 1B is an unrolled view of the stent of FIG. 1A in its expanded configuration.



FIG. 2A is an unrolled view of an unexpanded stent having variable strut lengths and sigmoidal shaped bridge members.



FIG. 2B is an unrolled view of the stent of FIG. 2A in its expanded configuration.



FIG. 3A is an unrolled view of an unexpanded stent having variable strut lengths and sigmoidal shaped bridge members with a transversely oriented portion.



FIG. 3B is an unrolled view of a stent similar to that shown in FIG. 3A but with less variability in strut lengths.



FIGS. 4A-4C show enlarged views of a stent having slanted bridge members under various operating conditions.



FIGS. 5A-5C show enlarged views of a stent having V-shaped bridge members under various operating conditions.



FIG. 6 shows a bridge member having strain relief regions.



FIG. 7A shows a bridge member having an arcuate surface.



FIG. 7B-1 and 7B-2 are cross-sectional views of the bridge member of FIG. 7A.



FIG. 7C shows a bridge member having a tapered region.



FIG. 8 shows a spring-like bridge member.



FIG. 9 shows an elastomeric bridge member.



FIG. 10A shows a bridge member slidably engaged with struts of adjacent tubular rings.



FIG. 10B is a side-view of the strut in FIG. 10A.



FIGS. 11A-11C show top and side views of a bridge member having an aperture.



FIG. 12 is a magnified view of a stent having helical bridge members.



FIG. 13 is an unrolled view of a stent having interleaving adjacent tubular rings.



FIGS. 14A-14C illustrate an exemplary method of deploying a prosthesis.





DETAILED DESCRIPTION OF THE INVENTION


FIGS. 1A and 1B show a commercially available stent 10 in an unrolled view, for ease of description. FIGS. 1A and 1B show a portion of the stent 10 in its unexpanded and expanded configurations, respectively. Stent 10 may be balloon expandable or self-expanding and is usually between 2 mm and 200 mm in length, although other lengths are possible. Most stents according to embodiments of the present invention will be self-expanding. Stent 10 may also be coated with a therapeutic agent, for example, an anti-restenosis agent such as, Paclitaxel, Rapamycin or derivatives thereof such as Biolimus A9. Stent 10, like most stents, generally comprises a plurality of tubular rings 11 (shown in FIGS. 1A-1B in an unrolled view) arranged axially adjacent one another. Each of the tubular rings 11 can be radially contracted and expanded. Each tubular ring 11 comprises a plurality of axially oriented struts 12. In the contracted configuration, struts 12 are parallel to the longitudinal axis of the stent 10. Generally, struts 12, and therefore each of the tubular rings 11, all share the same shape (usually rectangular) and dimensions to allow for uniform compression and expansion of the stent 10 as a whole. Circumferentially adjacent struts 12 are connected at a common longitudinal end by a U-shaped connector 13. Connectors 13 are placed on alternating pairs of struts 12 thereby forming an undulating pattern of peaks having apices circumferentially aligned with one another. In the expanded configuration, the U-shaped connector 13 deflects outwardly so that the struts 12 form a undulating pattern of lower frequency when compared to the stent 10 in the collapsed configuration. FIG. 1B illustrates stent 10 in the expanded configuration. A bridge member 14 connects two axially adjacent tubular rings 11 together through adjacent connectors 13a, 13b. Bridge members 14 may be present for each connector 13, for every other connector 13, or in other alternating patterns. The bridge member 14 limits the axial flexibility of stent 10. For example, the greater the number of bridge members 14, the less the axial flexibility of stent 10. On the other hand, a longer or thinner bridge member 14 increases stent 10 flexibility. As shown in FIGS. 1A-B, bridge members 14 are generally straight and have alternating slopes between adjacent tubular rings 11 coupling staggered U-connectors 13 between adjacent tubular rings 11. Alternatively, bridge members 14 may all share the same slope or may all be parallel to the longitudinal axis of the stent. Besides being slanted as shown in FIGS. 1A-1B, bridge members 14 may also have different shapes. For example, bridge members 14 may be S-shaped, V-shaped, U-shaped, Z-shaped, etc. and these alternative geometries are well documented in medical and patent literature. Like most stents, its component parts including struts 12, connectors 13 and bridge members 14 are each integral parts of the stent and may be laser cut or EDM machined from tubing, or stent 10 may be photoetched from flat stock, with its ends rolled into a tube and welded together. While these commercially available designs are promising, stent flexibility still remains a challenge, especially when longer stents are required to treat long lesions or when stents are delivered in torturous vessels.



FIGS. 2A and 2B show a portion of a stent 20 according to an exemplary embodiment of the present invention. Stent 20 has improved flexibility and is shown in FIGS. 2A and 2B in its unexpanded state and its expanded state, respectively. Stent 20 is generally similar to the conventional stents described above with several exceptions noted below. Stent 20 is preferably a self-expanding stent fabricated from Nitinol although it may also be balloon expandable and fabricated from stainless steel, cobalt chromium alloy or other materials commonly used in balloon expandable stents. Stent 20 comprises tubular rings 22 which are connected together by bridge members 27. Each tubular ring 22 comprises several circumferentially adjacent struts 21. Although struts 21 are axially oriented and share the same rectangular shape, they are not of uniform length. Each of the tubular rings 22 comprises axially-oriented struts of alternating lengths. In the embodiments shown in FIGS. 2A-B, tubular rings 22 comprises long struts 21a and short struts 21b. Within each tubular ring 22, a long strut 21a is followed by a short strut 21b, which is then followed by another short strut 21b, which is then followed by a long strut 21a, and so forth. The ends of struts 21 are connected together with a U-shaped connectors 26 thereby forming a series of high peaks 24 and low peaks 25. The apices of the high peaks 24 are axially offset from the apices of the low peaks 25 but the apices of both peaks face in the same direction. In the exemplary embodiment of FIGS. 2A-2B, each low peak 25 is followed by two high peaks 24. Other strut arrangement patterns and strut lengths are also possible. Using struts of different, alternating lengths creates the high 24 and low peaks 25 which form a larger gap between adjacent rings 22 without significantly decreasing scaffolding ability of the stent 20. Scaffolding ability is maintained because the high peaks 24 still provide support in the gap region between adjacent tubular rings 22.


The larger gap created between low peaks 25 of stent 20 allow bridge members 27 to be axially longer than if all peaks were the same height as in a conventional stent, thereby creating a longer beam which can deflect more. This permits greater axial flexibility between adjacent tubular rings 22. As seen in FIGS. 2A-2B, sigmoidally shaped bridge member 27 spans between axially adjacent peaks 25 and is axially oriented ends couple to the apex of U-shaped connector 26. Bridge members 27 may also span between one low peak 25 and one high peak 24 to create a bridge member having intermediate length and therefore intermediate flexibility, as compared to a bridge member between two high peaks 24. A greater variety of strut lengths and therefore a greater variety of peak “heights” can also be used. One of ordinary skill in the art will recognize that the bridge member 27 may also couple with other portions of the tubular ring 22 including a region of peak 25 that is off-center from the apex 26 or laterally with strut 21. Additionally, any number of tubular rings 22 may be used in order to create a stent of varying length, although in this exemplary embodiment the overall stent length is preferably between about 2 mm and about 200 mm with individual tubular rings ranging from about 2 mm to about 5 mm long. Thus a stent may be composed of anywhere from 1 to 100 individual rings. FIG. 2B illustrates stent 20 in the expanded state.



FIG. 3A shows another exemplary embodiment of the present invention. Stent 30 is similar to the embodiment shown in FIGS. 2A-2B, with the major difference being the shape of its bridge member 32. In stent 30, each tubular ring 33 comprises long struts 34a and shorter struts 34b which are connected together with a U-shaped connector 36 thereby forming a plurality of high peaks 37 and low peaks 38. High peaks 37 are higher than the low peaks 38. Bridge member 32 is generally sigmoidally shaped and includes a transverse portion 35 generally perpendicular to the longitudinal axis of the stent 30. The bridge member 33 allows adjacent tubular rings 33 to flex relative to one another. The transverse portion 35 in bridge member 32 has a length greater than the circumferential distance between a peak on one tubular ring 33 and a peak on an adjacent tubular ring 33. Thus, the transverse portion 35 helps provide axial stability to the stent 30 during deployment. Often, stents are constrained by a protective outer sheath during delivery. As the outer sheath is retracted during stent delivery, friction between the sheath and the stent may cause adjacent ring sections of a stent to advance towards one another with ends potentially interleaving and overlapping, thereby causing binding between the stent and sheath during deployment. The transverse portion 35 extends circumferentially between adjacent tubular rings 33, therefore transverse portion 35 serves as a stop to prevent adjacent tubular rings 33 from overlapping with one another due to friction with a sheath during retraction and stent deployment. Therefore, using variable strut lengths allows a larger gap between adjacent tubular rings 33 to be created in order to accommodate the bridge member 32 having a transverse portion 35, resulting in a more axially stable stent 30.



FIG. 3B shows a stent similar to the embodiment of FIG. 3A with the major exception being that the height between high peaks 37a and low peaks 38a is less than the distance between high and low peaks 37, 38. Peak height is adjusted by varying the length of the axially oriented struts in stent 31. Stent 31 has long struts 34a and shorter struts 34c, yet in this embodiment strut 34c is longer than the short strut 34b in the previous embodiment. Reducing the height between high and low peaks 37a, 37b allows a bridge member 32 to be utilized having a shorter axial length than the embodiment of FIG. 3A, therefore axial rigidity of stent 31 may be adjusted as desired.


As previously described, conventional stents have bridge members which connect adjacent tubular rings. Several embodiments of bridge members that may be used in the stent embodiments previously disclosed are described herein below. FIGS. 4A-4C and FIGS. 5A-5C show the bridge members commonly used in existing stents and which may also be used in any of the embodiments described herein. FIGS. 4A, 4B and 4C show a sigmoidal bridge member 42 in a neutral, tensile and compressed configuration, respectively. Bridge member 42 spans between a connector 44a and a connector 44b. Connectors 44a, 44b link circumferentially adjacent struts 45 together. As shown in FIGS. 4A-4C, the peaks of connectors 44a and 44b may not share the same longitudinal axis and thus they are offset from one another. Therefore, any bridge member between the connectors is slanted relative to the longitudinal axis of the stent. FIGS. 5A-5C show bridge members 52 having a V-shape. FIGS. 5A, 5B and 5C show the bridge members 52 in a neutral, tensile and compressed configuration, respectively. Bridge member 52 spans between peaks of connectors 55a and 55b which share the same longitudinal axis. These and other bridge member shapes, such an “S”, “U”, “Z”, etc., are used in conventional stents and can be used in embodiments of the present invention.


An aspect of the present invention provides stent bridge members which increase the axial flexibility of the stent. FIG. 6 shows a bridge member 62 according to embodiments of the present invention. Bridge member 62 spans between axially adjacent peaks 63a and 63b and generally has two axially oriented sections coupled together with a transverse section 64 forming a stairway step shape. There are cut-away regions 66 (as marked by the dotted lines) located on the inside corners of the bridge member 62 as it transitions from being parallel to the longitudinal axis of the stent to being perpendicular. Cut-away regions 66 are strain relief regions which increase the flexibility of bridge member 62. Cut-away regions may alternatively be located on other regions of the bridge member 62.


FIGS. 7A and 7B-1 and 7B-2 show another bridge member 72, and associated cross-sectional views respectively, according to embodiments of the present invention. Conventional stents have a uniform thickness throughout. Bridge member 72 has an arcuate surface thinner than the thickness of struts 74 and connectors 77. This is best seen in FIG. 7B-1 which shows a cross section of bridge member 72 taken along line 7B-7B between adjacent connectors 77a and 77b. The arcuate surface may be created by grinding material away from the original surface 72a of bridge member 72 using techniques such as laser ablation, sanding, water blasting, or the like. The bridge member 72 is thus thinner and has greater flexibility. As shown in FIG. 7B, the cross-section of bridge member 72 is concave on one side and convex on the opposite side. Alternatively, bridge member 72 may be curved on only one side as shown in alternate cross section in FIG. 7B-2. Other bridge member geometries may also be used. For example bridge member 72 may have a thicknesses less than that of the struts and connectors, or the overall width of the bridge member 72 can also be reduced as seen in FIG. 7C. In both cases, increased flexibility of the stent results from a thinner bridge member.



FIG. 8 shows another bridge member according to embodiments of the present invention. Bridge member 81 is spring-like and thus provides a high degree of flexibility in all directions. Unlike the bridge members previously described which are cut from the same material as the remainder of the stent, bridge member 81 may be laser cut and then formed separately over adjacent strut connectors 82a and 82b. Bridge member 81 may then be welded, bonded or otherwise attached to adjacent tubular stent rings thereby coupling them together.



FIG. 9 shows another bridge member according to embodiments of the present invention. In this embodiment, bridge member 92 comprises an elastomer which can be resiliently stretched in any direction, thus increasing the axial flexibility of the stent. For example, the elastomer may be rubber or a rubber-like material such as synthetic rubber and latex.



FIGS. 10A-10B show another bridge member according to embodiments of the present invention. Bridge member 102 traverses between strut connectors 103a and 103b. FIG. 10B shows a cross section of a strut connector 103 taken along line 10B-10B. Strut connector 103 has a longitudinal aperture 104 in a plane generally parallel to the outer surface of the stent. Bridge member 102 traverses between strut connectors 103a and 103b and is received in apertures 104a and 104b, thus slidably coupling the two. Bridge member 102 also includes end portion 106a, 106b on each of its two longitudinal ends. Enlarged head regions 106a, 106b have a greater cross-sectional area than aperture 104a, 104b, restricting the axial movement of the connectors 103a and 103b relative to one another. Head regions 106a, 106b may be formed for example by folding the ends of the bridge member over itself or welding the enlarged region to the axial portion of bridge member 102.



FIGS. 11A-11C show another bridge member according to embodiments of the present invention. Bridge member 112 has at least one aperture 115 through its width. The apertures 115 have an axis that is generally parallel to the outer surface of the stent. FIG. 11B is a side-view of FIG. 11A and shows three apertures while FIG. 11C is also a side-view of FIG. 11A and shows an alternative embodiment having an oval-shaped aperture. Other shapes and numbers of apertures may be used as well. Having at least one aperture through the width of the bridge member 112 increases the overall flexibility of the stent.



FIG. 12 shows a portion of a stent 120 having bridge members according to another embodiment of the present invention. Helical bridge member 122 comprises a bar having a section rotated approximately 90 degrees and a second section rotated another 90 degrees to form a helix with portions of the bar generally in two planes that are orthogonal to one another. Helical bridge member 122 may also be formed by a bar rotated multiple times. By rotating the bridge in such a manner, helical bridge member 122 has a greater degree of axial flexibility than a simple single plane bridge member without sacrificing the radial strength of the stent. The bridge member 122 may be formed separately from the remainder of the stent 120 and then welded or otherwise attached thereto in a secondary process, or individual bridge members 122 may be helically rotated in an integrally formed stent.



FIG. 13 shows yet another embodiment a stent having variable strut lengths in order to produce a more flexible stent. This embodiment is similar to previous embodiments with the major difference being that the gap created by high and low peaks is used to allow adjacent tubular rings to overlap or interleave with one another. Adjacent tubular rings are coupled together with a shorter bridge connector. FIG. 13 is a rolled out view of a stent 130 having interleaving peaks. Stent 130 comprises a plurality of tubular rings 131 each having low 132b and high peaks 132a. The tubular rings are in close, axial proximity with one another such that the peak of one of the tubular rings is nested between the recess 133 formed by two peaks of an adjacent tubular ring. In other words, the peaks interleave, providing better stability for the stent 130 in its compressed or crimped state. Because of the enhanced stability of the stent 130, fewer bridge members are required to couple adjacent tubular rings 131 together, thus the overall stent is more flexible even though shorter bridge members are used. As with the embodiments previously described, the peaks 132a, 132b are formed by U-shaped connectors 135 which connect circumferentially adjacent struts 136. A short, bridge member 137 is occasionally formed laterally between adjacent peaks. In other words, the bridge members 137 are attached to connectors on areas of the connector offset from the apex of its peak. Overall length of stent 130 is similar to that disclosed for previous embodiments and thus stent 130 ranges in length from about 2 mm to about 200 mm.


The circumferentially adjacent struts 136 of stent 130 form a repeating sequence of four struts having three different lengths. The sequence comprises a short length strut 138a followed by a medium length strut 138b which is then followed by a long length strut 138c which is followed by another medium length strut 138b.


In preferred embodiments of FIG. 13, strut thickness is constant throughout each tubular ring and strut width is varied. The longest strut 138c has the largest strut width, the shortest strut 138a has the smallest strut width, and the intermediate length struts 138b have a width in between the width of the longest and shortest struts 138c and 138a. This configuration helps to ensure uniform strut expansion and thus uniform vessel scaffolding. In still other embodiments, variable strut thickness may be employed exclusively or in combination with variable strut width and variable strut length.



FIGS. 14A-14C illustrate an exemplary method of deploying the stents disclosed herein. In FIG. 14A, a single stent 1506 is disposed over a catheter shaft 1504 in delivery system 1500. In other embodiments, multiple stents may be carried by the catheter shaft 1504. Delivery system 1500 is introduced and advanced in an artery V over a guidewire GW to lesion L using standard catheterization techniques well known in the art. Stent 1506 is a self-expanding prosthesis having multiple tubular rings coupled together and interleaving with one another as illustrated in FIG. 13. Outer sheath 1502 constrains stent 1506 and prevents it from expanding until it is properly positioned adjacent lesion L in vessel V. Once the physician has properly positioned stent 1506, outer sheath 1502 is retracted relative to pusher tube 1512 allowing stent 1506 to self-expand into its expanded configuration 1508 into lesion L. FIG. 14B shows expanded stent 1508 after the sheath 1502 has been retracted. In some embodiments, stent 1506 may also be coated, impregnated, infused or otherwise coupled with one or more drugs that inhibit restenosis, such as Rapamycin, Everolimus, Biolimus A9, Paclitaxel, derivates, prodrugs, or derivatives of the aforementioned, or other suitable agents, preferably carried in a durable or bioerodable carrier of polymeric or other suitable material. Alternatively, the stent 1506 may be coated with other types of drugs or therapeutic materials such as antibiotics, thrombolytics, anti-thrombotics, anti-inflammatories, cytotoxic agents, anti-proliferative agents, vasodilators, gene therapy agents, radioactive agents, immunosuppressants, chemotherapeutics, endothelial cell attractors or promoters and/or stem cells. Such materials may be coated over all or a portion of the surface of the stent or the stent may have a porous structure or include apertures, holes, channels, or other features in which such materials may be deposited.


Additionally, as previously mentioned, delivery catheter 1500 in this exemplary embodiment only carries a single stent 1506. However, in other embodiments, delivery catheter 1500 may carried multiple stents. For example, a delivery catheter 1500 may carry two stents 1506, 1510. After the first stent is deployed at a first lesion as seen in FIG. 14B, the delivery catheter 1500 may be repositioned to another lesion L as seen in FIG. 14C. Outer sheath 1502 may then be retracted again, allowing the second stent 1510 to self-expand into the second lesion, L. In addition to deploying multiple stents at multiple sites, multiple stents may also be deployed at a single treatment site, thereby customizing stent length. Additional disclosure relating to systems which may be for deployment of customized stent lengths, including any of the stents disclosed herein is disclosed in U.S. Patent Publication Nos. 2007/0027521 and 2006/0282150, the entire contents of which are incorporated herein by reference. Additionally, delivery systems which may be used with any of the stents disclosed herein and which may help to control stent delivery due to the tendency of the stent to jump away from the delivery catheter are disclosed in U.S. patent application Ser. No. 11/752,448, the entire contents of which are also incorporated herein by reference.


While the exemplary embodiments have been described in some details for clarity of understanding and by way of example, a variety of additional modifications, adaptations and changes may be clear to those of skill in the art. Hence, the scope of the present invention is limited solely by the appended claims.

Claims
  • 1. A tubular prosthesis comprising: a plurality of tubular rings radially expandable from a contracted configuration to an expanded configuration, each ring comprising a plurality of axially oriented struts interconnected so as to form a plurality of high peaks and a plurality of low peaks, the plurality of high peaks and the plurality of low peaks being circumferentially arranged to form an alternating series of at least one high peak and at least one low peak, the high and low peaks having apices oriented in the same axial direction, the apices of the high peaks being axially offset from the apices of the low peaks, the apices of the high peaks being axially aligned with one another, the apices of low peaks being axially aligned with one another; andat least one non-linear bridge member coupling each pair of adjacent tubular rings together, the at least one non-linear bridge member having a first end connected to a first low peak in a first tubular ring of a respective pair of adjacent tubular rings and a second end connected to a second low peak in a second tubular ring of the respective pair of adjacent tubular rings, and a non-linear intermediate portion extending between the first and second ends, wherein the non-linear intermediate portion includes a transverse portion extending in a direction perpendicular to a longitudinal axis of the tubular prosthesis when the prosthesis is in the contracted configuration,wherein the apices of the high and low peaks in the first tubular ring are circumferentially offset from the apices of the high and low peaks in the second tubular ring such that the first low peak in the first tubular ring is circumferentially offset from the second low peak in the second tubular ring, andwherein each and every bridge member of the prosthesis extends circumferentially between adjacent unconnected high peaks of the first and second adjacent tubular rings of the respective pair of adjacent tubular rings connected by the respective bridge member and extends a length greater than a circumferential distance between the respective adjacent unconnected high peaks of the respective pair of adjacent tubular rings such that the respective bridge member inhibits contact between and overlapping of the adjacent unconnected high peaks of the respective adjacent tubular rings during flexure of the tubular prosthesis in the contracted configuration,wherein the non-linear bridge member includes a portion, between the first end and the second end, having a reduced thickness by curving inward on only one side to facilitate flexibility between the first and second tubular rings coupled with the non-linear bridge member.
  • 2. The tubular prosthesis of claim 1, wherein each high peak comprises a long strut having a first length and each low peak comprises a short strut having a second length shorter than the first length.
  • 3. The tubular prosthesis of claim 1, wherein the plurality of axially oriented struts comprise long struts and short struts, the short struts shorter than the long struts and wherein the plurality of axially oriented struts are arranged circumferentially such that each short strut is disposed between one long strut and one short strut.
  • 4. The tubular prosthesis of claim 1, wherein the low and the high peaks are arranged circumferentially such that each high peak is disposed between one low peak and one high peak.
  • 5. The tubular prosthesis of claim 1, wherein the apices of the high and low peaks of the first tubular ring point toward the apices of the high and low peaks of the second tubular ring.
  • 6. The tubular prosthesis of claim 1, wherein the first low peak is circumferentially offset from the high peak in the second tubular ring.
  • 7. The tubular prosthesis of claim 1, wherein each low peak comprises two short struts.
  • 8. The tubular prosthesis of claim 1, wherein each high peak comprises one long strut and one short strut, the short strut shorter than the long strut.
  • 9. The tubular prosthesis of claim 1, wherein each high peak comprises one long strut and one short strut, the long strut having a first width and the short strut having a second width less than the first.
  • 10. The tubular prosthesis of claim 1, wherein the bridge member is sigmoidal shaped.
  • 11. The tubular prosthesis of claim 1, wherein the bridge member has a z-shape.
  • 12. The tubular prosthesis of claim 1, wherein the bridge member comprises a surface defining one or more apertures therein.
  • 13. The tubular prosthesis of claim 12, wherein the apertures extend entirely through the bridge member.
  • 14. The tubular prosthesis of claim 12, wherein the apertures have an axis parallel to an outer surface of the prosthesis.
  • 15. The tubular prosthesis of claim 12, wherein at least one of the apertures form an elongate slot.
  • 16. The tubular prosthesis of claim 1, wherein the bridge member has a thickness in a radial direction, the thickness varying across the bridge member.
  • 17. The tubular prosthesis of claim 1, wherein the bridge member, from the first end to the second end, defines a step shape and further includes a strain relief region, the strain relief region comprising an area with a reduced width where the bridge member transitions from being parallel to the longitudinal axis to being perpendicular to the longitudinal axis.
  • 18. The tubular prosthesis of claim 1, wherein the bridge member has a first radial thickness and the plurality of axially oriented struts have a second radial thickness different than the first thickness.
  • 19. The tubular prosthesis of claim 18, wherein the first radial thickness is less than the second radial thickness.
  • 20. The tubular prosthesis of claim 1, wherein the bridge member comprises a resilient elastomer.
  • 21. The tubular prosthesis of claim 1, wherein adjacent struts of each of the tubular rings of the plurality are connected by a connector, and the bridge member is slidably engaged with the connector.
  • 22. The tubular prosthesis of claim 1, wherein the bridge member comprises a first axially oriented portion such that the transverse portion extends transverse to the first axially oriented portion and is coupled thereto.
  • 23. The tubular prosthesis of claim 22, wherein the bridge member further comprises a second axially oriented portion, the transverse portion disposed between the first and second axially oriented portions.
  • 24. The tubular prosthesis of claim 1, wherein the bridge member has an axial length between the first and second ends longer than the axial distance between high peaks on adjacent tubular rings.
  • 25. The tubular prosthesis of claim 1, wherein the bridge member has an axial length between the first and second ends longer than the axial distance between a high peak and a low peak on adjacent tubular rings.
  • 26. The tubular prosthesis of claim 1, wherein the first tubular ring is disposed between the second tubular ring and a third tubular ring, the first tubular ring being connected to the third tubular ring by a second bridge member.
  • 27. The tubular prosthesis of claim 26, wherein the bridge member has a first orientation and the second bridge member has a second orientation, wherein the second orientation is a mirror image of the first orientation.
  • 28. The tubular prosthesis of claim 26, wherein the bridge member has a first slope and the second bridge member has a second slope, the second slope being opposite the first slope.
  • 29. The tubular prosthesis of claim 1, wherein the first end of the bridge member connects to the first low peak at the apex thereof.
  • 30. The tubular prosthesis of claim 1, wherein the second end of the bridge member connects to the apex of the low peak in the adjacent tubular ring.
  • 31. The tubular prosthesis of claim 1, further comprising a therapeutic agent carried by the prosthesis and adapted to being released therefrom at a controlled rate.
  • 32. The tubular prosthesis of claim 1, wherein the plurality of tubular rings are self-expanding.
  • 33. The tubular prosthesis of claim 1, wherein the tubular prosthesis has a length in the range from about 2 mm to about 200 mm.
  • 34. The tubular prosthesis of claim 1, wherein each of the plurality of tubular rings has the same axial length.
  • 35. The tubular prosthesis of claim 1, further comprising a third tubular ring adjacent the first tubular ring and unconnected thereto.
  • 36. The tubular prosthesis of claim 35, further comprising a fourth tubular ring unconnected to but deployable with the first or third tubular ring.
  • 37. The tubular prosthesis of claim 1, wherein the entire transverse portion is oriented perpendicular to the longitudinal axis of the tubular prosthesis, the transverse portion being disposed between a first peak on the first tubular ring and a second peak on the second tubular ring thereby preventing the first peak from overlapping with the second peak when the tubular prosthesis is in compression.
  • 38. The tubular prosthesis of claim 1, wherein the bridge member comprises an axial portion and a circumferential portion transverse thereto.
  • 39. The tubular prosthesis of claim 1, wherein the bridge member has a width equivalent to a width of the axial struts.
  • 40. The tubular prosthesis of claim 1, wherein the bridge member comprises a first axially oriented region which includes the first end, and a second axially oriented region which includes the second end.
  • 41. The tubular prosthesis of claim 1, wherein the plurality of struts are parallel when in the contracted configuration.
  • 42. The tubular prosthesis of claim 1, wherein the bridge member comprises two axially oriented sections coupled together with a transverse section forming a step shape.
  • 43. A tubular prosthesis comprising: a plurality of tubular rings radially expandable from a contracted configuration to an expanded configuration, each ring comprising a plurality of axially oriented struts interconnected so as to form a plurality of high peaks and a plurality of low peaks, the plurality of high peaks and the plurality of low peaks being circumferentially arranged to form an alternating series of high peaks and low peaks, the high and low peaks having apices oriented in the same axial direction, the apices of the high peaks being axially offset from the apices of the low peaks, the apices of the high peaks being substantially axially aligned with one another, the apices of the low peaks being substantially axially aligned with one another,wherein each strut of the plurality has a width and is connected to a circumferentially adjacent strut of the plurality of struts at a common longitudinal end by a U-shaped connector,wherein each pair of adjacent tubular rings of the plurality of tubular rings are circumferentially offset from one another such that a high peak on a first tubular ring of a respective pair of adjacent tubular rings is disposed circumferentially between two high peaks on a second tubular ring of the respective pair of adjacent tubular rings along a longitudinal axis of the prosthesis; anda plurality of bridge members coupling each pair of adjacent tubular rings together, each and every bridge member having a first end connected to a low peak of the first tubular ring and a second end connected to a low peak of the adjacent tubular ring,wherein the first end of the bridge member is circumferentially offset from the second end of the bridge member,wherein each bridge member has a non-linear intermediate portion extending between the first and second ends, wherein the non-linear intermediate portion includes a transverse portion extending in a direction perpendicular to the longitudinal axis of the tubular prosthesis when the prosthesis is in the contracted configuration,wherein each and every bridge member of the prosthesis extends circumferentially between adjacent unconnected high peaks of first and second adjacent tubular rings of the respective adjacent pair of tubular rings connected by the respective bridge member and extends a length greater than a circumferential distance between the respective adjacent unconnected high peaks of the respective pair of adjacent tubular rings such that the respective bridge member inhibits contact between and overlapping of the unconnected adjacent high peaks of the respective adjacent tubular rings during flexure of the tubular prosthesis in the contracted configuration,wherein the non-linear bridge member includes a portion, between the first end and the second end, having a reduced thickness by curving inward on only one side to facilitate flexibility between the first and second tubular rings coupled with the non-linear bridge member.
  • 44. The tubular prosthesis of claim 43, wherein each high and low peak is separated from an adjacent high or low peak by a valley, and wherein the circumferential width of each valley in the contracted configuration is less than the circumferential width of each peak in the contracted configuration.
  • 45. The tubular prosthesis of claim 43, wherein the high and low peaks circumferentially alternate with one another in the first tubular ring.
  • 46. The tubular prosthesis of claim 43, wherein the apices of the high and low peaks in the first tubular ring are circumferentially offset from the apices of the high and low peaks in the adjacent tubular ring.
  • 47. The tubular prosthesis of claim 43, wherein each high peak comprises a long strut having a first length and each low peak comprises a short strut having a second length shorter than the first length.
  • 48. The tubular prosthesis of claim 43, wherein the plurality of axially oriented struts comprise long struts and short struts, the short struts shorter than the long struts and wherein the plurality of axially oriented struts are arranged circumferentially such that each short strut is disposed between one long strut and one short strut.
  • 49. The tubular prosthesis of claim 48, wherein the long struts have a first width and the short struts have a second width less than the first width.
  • 50. The tubular prosthesis of claim 43, wherein the low and the high peaks are arranged circumferentially such that each high peak is disposed between two low peaks.
  • 51. The tubular prosthesis of claim 43, wherein the apices of the high and low peaks of the first tubular ring point toward the apices of the high and low peaks of the adjacent tubular ring.
  • 52. The tubular prosthesis of claim 43, wherein each high and low peak is separated from an adjacent high or low peak by a valley, and wherein the high peaks on the first tubular ring are nested between valleys on the adjacent tubular ring.
  • 53. The tubular prosthesis of claim 43, wherein the apices of the low peaks in the first tubular ring are circumferentially aligned with the apices of the high peaks in the adjacent tubular ring.
  • 54. The tubular prosthesis of claim 43, wherein the first tubular ring is disposed between the adjacent tubular ring and a third tubular ring, the first tubular ring being connected to the third tubular ring with a second bridge member.
  • 55. The tubular prosthesis of claim 54, wherein the bridge member has a first orientation and the second bridge member has a second orientation, wherein the second orientation is a mirror image of the first orientation.
  • 56. The tubular prosthesis of claim 43, wherein the first end of the bridge member connects to a portion of a first peak offset from the apex thereof in the first tubular ring.
  • 57. The tubular prosthesis of claim 43, wherein the second end of the bridge member connects to a portion of a peak offset from the apex thereof in the adjacent tubular ring.
  • 58. The tubular prosthesis of claim 43, further comprising a therapeutic agent carried by the prosthesis and adapted to being released therefrom at a controlled rate.
  • 59. The tubular prosthesis of claim 43, wherein the plurality of tubular rings are self-expanding.
  • 60. The tubular prosthesis of claim 43, wherein the tubular prosthesis has a length in the range from about 2 mm to about 200 mm.
  • 61. The tubular prosthesis of claim 43, wherein each of the plurality of tubular rings has the same axial length.
  • 62. The tubular prosthesis of claim 43, further comprising a third tubular ring adjacent the first tubular ring and unconnected thereto.
  • 63. The tubular prosthesis of claim 62, further comprising a fourth tubular ring unconnected to but deployable with the first or third tubular ring.
  • 64. The tubular prosthesis of claim 43, wherein each of the high peaks has the same shape and dimension as an adjacent high peak on each ring.
US Referenced Citations (574)
Number Name Date Kind
4069825 Akiyama Jan 1978 A
4468224 Enzmann et al. Aug 1984 A
4512338 Balko et al. Apr 1985 A
4564014 Fogarty et al. Jan 1986 A
4580568 Gianturco Apr 1986 A
4681110 Wiktor Jul 1987 A
4690684 McGreevy et al. Sep 1987 A
4733665 Palmaz Mar 1988 A
4739762 Palmaz Apr 1988 A
4748982 Horzewski et al. Jun 1988 A
4762129 Bonzel Aug 1988 A
4770176 McGreevy et al. Sep 1988 A
4775337 Van Wagener et al. Oct 1988 A
4776337 Palmaz Oct 1988 A
4886062 Wiktor Dec 1989 A
4891225 Langer et al. Jan 1990 A
4950227 Savin et al. Aug 1990 A
4988356 Crittenden et al. Jan 1991 A
4994066 Voss Feb 1991 A
4994069 Ritchart et al. Feb 1991 A
4994298 Yasuda Feb 1991 A
5013318 Spranza, III May 1991 A
5035706 Giantureo et al. Jul 1991 A
5040548 Yock Aug 1991 A
5061273 Yock Oct 1991 A
5064435 Porter Nov 1991 A
5092877 Pinchuk Mar 1992 A
5102417 Palmaz Apr 1992 A
5104404 Wolff Apr 1992 A
5122154 Rhodes Jun 1992 A
5135535 Kramer Aug 1992 A
5158548 Lau et al. Oct 1992 A
5192297 Hull Mar 1993 A
5195984 Schatz Mar 1993 A
5201757 Heyn et al. Apr 1993 A
5217495 Kaplan et al. Jun 1993 A
5219355 Parodi et al. Jun 1993 A
5226913 Pinchuk Jul 1993 A
5246421 Saab Sep 1993 A
5261887 Walker Nov 1993 A
5273536 Savas Dec 1993 A
5282823 Schwartz et al. Feb 1994 A
5282824 Gianturco Feb 1994 A
5300085 Yock Apr 1994 A
5312415 Palermo May 1994 A
5328469 Coletti Jul 1994 A
5334187 Fischell et al. Aug 1994 A
5391172 Williams et al. Feb 1995 A
5421955 Lau et al. Jun 1995 A
5443498 Fontaine Aug 1995 A
5445646 Euteneuer et al. Aug 1995 A
5456713 Chuter Oct 1995 A
5458615 Klemm et al. Oct 1995 A
5470315 Adams Nov 1995 A
5478349 Nicholas Dec 1995 A
5484444 Braunschweiler et al. Jan 1996 A
5490837 Blaeser et al. Feb 1996 A
5496346 Horzewski et al. Mar 1996 A
5501227 Yock Mar 1996 A
5507768 Lau et al. Apr 1996 A
5507771 Gianturco Apr 1996 A
5514093 Ellis et al. May 1996 A
5514154 Lau et al. May 1996 A
5522882 Gaterud et al. Jun 1996 A
5527354 Fontaine et al. Jun 1996 A
5531735 Thompson Jul 1996 A
5533968 Muni et al. Jul 1996 A
5534007 St. Germain et al. Jul 1996 A
5545209 Roberts et al. Aug 1996 A
5549551 Peacock, III et al. Aug 1996 A
5549563 Kronner Aug 1996 A
5549635 Solar Aug 1996 A
5554181 Das Sep 1996 A
5562725 Schmitt et al. Oct 1996 A
5571086 Kaplan et al. Nov 1996 A
5591195 Taheri et al. Jan 1997 A
5593412 Martinez et al. Jan 1997 A
5607444 Lam Mar 1997 A
5607463 Schwartz et al. Mar 1997 A
5628755 Heller et al. May 1997 A
5628775 Jackson et al. May 1997 A
5634928 Fischell et al. Jun 1997 A
5639274 Fischell et al. Jun 1997 A
5662675 Polanskyj Stockert et al. Sep 1997 A
5662703 Yurek et al. Sep 1997 A
5670161 Healy et al. Sep 1997 A
5676654 Ellis et al. Oct 1997 A
5683451 Lenker et al. Nov 1997 A
5690644 Yurek et al. Nov 1997 A
5693085 Buirge et al. Dec 1997 A
5697948 Marin et al. Dec 1997 A
5697971 Fischell et al. Dec 1997 A
5702418 Ravenscroft Dec 1997 A
5702419 Berry et al. Dec 1997 A
5709701 Parodi Jan 1998 A
5716393 Lindenberg et al. Feb 1998 A
5722669 Shimizu et al. Mar 1998 A
5723003 Winston et al. Mar 1998 A
5735869 Fernandez-Aceytuno Apr 1998 A
5741323 Pathak et al. Apr 1998 A
5749848 Jang et al. May 1998 A
5749890 Shaknovich May 1998 A
5749921 Lenker et al. May 1998 A
5755697 Jones et al. May 1998 A
5755772 Evans et al. May 1998 A
5755776 Al-Saadon May 1998 A
5755781 Jayaraman May 1998 A
5769882 Fogarty et al. Jun 1998 A
5772669 Vrba Jun 1998 A
5776141 Klein et al. Jul 1998 A
5792144 Fischell et al. Aug 1998 A
5797951 Mueller et al. Aug 1998 A
5800519 Sandock Sep 1998 A
5807398 Shaknovich Sep 1998 A
5824040 Cox et al. Oct 1998 A
5824041 Lenker et al. Oct 1998 A
5833694 Poncet Nov 1998 A
5836964 Richter et al. Nov 1998 A
5843090 Schuetz Dec 1998 A
5843092 Heller et al. Dec 1998 A
5855563 Kaplan et al. Jan 1999 A
5858556 Eckert et al. Jan 1999 A
5870381 Kawasaki et al. Feb 1999 A
5879370 Fischell et al. Mar 1999 A
5891190 Boneau Apr 1999 A
5895398 Wensel et al. Apr 1999 A
5899935 Ding May 1999 A
5902332 Schatz May 1999 A
5919175 Sirhan Jul 1999 A
5921971 Agro et al. Jul 1999 A
5922020 Klein et al. Jul 1999 A
5941869 Patterson et al. Aug 1999 A
5951585 Cathcart et al. Sep 1999 A
5961536 Mickley et al. Oct 1999 A
5965879 Leviton Oct 1999 A
5968069 Dusbabek et al. Oct 1999 A
5972027 Johnson Oct 1999 A
5976107 Mertens et al. Nov 1999 A
5976155 Foreman et al. Nov 1999 A
5980484 Ressemann et al. Nov 1999 A
5980486 Enger Nov 1999 A
5980514 Kupiecki et al. Nov 1999 A
5980552 Pinchasik et al. Nov 1999 A
5984957 Laptewicz, Jr. et al. Nov 1999 A
5989280 Euteneuer et al. Nov 1999 A
5993484 Shmulewitz Nov 1999 A
5997563 Kretzers et al. Dec 1999 A
6004328 Solar Dec 1999 A
6007517 Anderson Dec 1999 A
6010530 Goicoechea Jan 2000 A
6022359 Frantzen Feb 2000 A
6022374 Imran Feb 2000 A
6027519 Stanford Feb 2000 A
6033434 Borghi Mar 2000 A
6036725 Avellanet Mar 2000 A
6039721 Johnson et al. Mar 2000 A
6042589 Marianne Mar 2000 A
6050999 Paraschac et al. Apr 2000 A
6056722 Jayaraman May 2000 A
6063111 Hieshima et al. May 2000 A
6066155 Amann et al. May 2000 A
6068655 Seguin et al. May 2000 A
6070589 Keith et al. Jun 2000 A
6090063 Makower et al. Jul 2000 A
6090136 McDonald et al. Jul 2000 A
6102942 Ahari Aug 2000 A
6106530 Harada Aug 2000 A
RE36857 Euteneuer et al. Sep 2000 E
6120477 Campbell et al. Sep 2000 A
6120522 Vrba et al. Sep 2000 A
6123712 Di Caprio et al. Sep 2000 A
6123723 Konya et al. Sep 2000 A
6126685 Lenker et al. Oct 2000 A
6129756 Kugler Oct 2000 A
6132460 Thompson Oct 2000 A
6139572 Campbell et al. Oct 2000 A
6143016 Bleam et al. Nov 2000 A
6165167 Delaloye Dec 2000 A
6165210 Lau et al. Dec 2000 A
6171334 Cox Jan 2001 B1
6179878 Duerig Jan 2001 B1
6183509 Dibie Feb 2001 B1
6187034 Frantzen Feb 2001 B1
6190402 Horton et al. Feb 2001 B1
6196995 Fagan Mar 2001 B1
6200337 Moriuchi et al. Mar 2001 B1
6217585 Houser et al. Apr 2001 B1
6238991 Suzuki May 2001 B1
6241691 Ferrera et al. Jun 2001 B1
6241758 Cox Jun 2001 B1
6248122 Klumb et al. Jun 2001 B1
6251132 Ravenscroft et al. Jun 2001 B1
6251134 Alt et al. Jun 2001 B1
6254612 Hieshima Jul 2001 B1
6254628 Wallace et al. Jul 2001 B1
6258117 Camrud et al. Jul 2001 B1
6264688 Herklotz et al. Jul 2001 B1
6267783 Letendre et al. Jul 2001 B1
6270524 Kim Aug 2001 B1
6273895 Pinchuk et al. Aug 2001 B1
6273911 Cox et al. Aug 2001 B1
6273913 Wright et al. Aug 2001 B1
6287291 Bigus et al. Sep 2001 B1
6312458 Golds Nov 2001 B1
6315794 Richter Nov 2001 B1
6319277 Rudnick et al. Nov 2001 B1
6322586 Monroe et al. Nov 2001 B1
6325823 Horzewski et al. Dec 2001 B1
6334871 Dor et al. Jan 2002 B1
6340366 Wijay Jan 2002 B2
6344272 Oldenburg et al. Feb 2002 B1
6348065 Brown et al. Feb 2002 B1
6350252 Ray et al. Feb 2002 B2
6350277 Kocur Feb 2002 B1
6357104 Myers Mar 2002 B1
6361558 Hieshima et al. Mar 2002 B1
6375676 Cox Apr 2002 B1
6379365 Diaz Apr 2002 B1
6383171 Gifford et al. May 2002 B1
6394995 Solar et al. May 2002 B1
6409753 Brown et al. Jun 2002 B1
6415696 Erickson et al. Jul 2002 B1
6416543 Hilaire et al. Jul 2002 B1
6419693 Fariabi Jul 2002 B1
6425898 Wilson et al. Jul 2002 B1
6428811 West et al. Aug 2002 B1
6451025 Jervis Sep 2002 B1
6451050 Rudakov et al. Sep 2002 B1
6464720 Boatman et al. Oct 2002 B2
6468298 Pelton Oct 2002 B1
6468299 Stack et al. Oct 2002 B2
6485510 Camrud et al. Nov 2002 B1
6488694 Lau et al. Dec 2002 B1
6488702 Besselink Dec 2002 B1
6511468 Cragg et al. Jan 2003 B1
6520986 Martin et al. Feb 2003 B2
6520987 Plante Feb 2003 B1
6527789 Lau et al. Mar 2003 B1
6527799 Shanley Mar 2003 B2
6530944 West et al. Mar 2003 B2
6540777 Stenzel Apr 2003 B2
6551350 Thornton et al. Apr 2003 B1
6555157 Hossainy Apr 2003 B1
6558415 Thompson May 2003 B2
6562067 Mathis May 2003 B2
6565599 Hong et al. May 2003 B1
6569180 Sirhan et al. May 2003 B1
6575993 Yock Jun 2003 B1
6579305 Lashinski Jun 2003 B1
6579309 Loos et al. Jun 2003 B1
6582394 Reiss et al. Jun 2003 B1
6582460 Cryer Jun 2003 B1
6585756 Strecker Jul 2003 B1
6589273 McDermott Jul 2003 B1
6592549 Gerdts et al. Jul 2003 B2
6599296 Gillick et al. Jul 2003 B1
6599314 Mathis Jul 2003 B2
6602226 Smith et al. Aug 2003 B1
6602282 Yan Aug 2003 B1
6605062 Hurley et al. Aug 2003 B1
6605109 Fiedler Aug 2003 B2
6607553 Healy et al. Aug 2003 B1
6613074 Mitelberg et al. Sep 2003 B1
6629992 Bigus et al. Oct 2003 B2
6645517 West Nov 2003 B2
6645547 Shekalim et al. Nov 2003 B1
6656212 Ravenscroft et al. Dec 2003 B2
6660031 Tran et al. Dec 2003 B2
6660381 Halas et al. Dec 2003 B2
6663660 Dusbabek et al. Dec 2003 B2
6666883 Seguin et al. Dec 2003 B1
6676693 Belding et al. Jan 2004 B1
6676695 Solem Jan 2004 B2
6679909 McIntosh et al. Jan 2004 B2
6685730 West et al. Feb 2004 B2
6692465 Kramer Feb 2004 B2
6699280 Camrud et al. Mar 2004 B2
6699281 Vallana et al. Mar 2004 B2
6699724 West et al. Mar 2004 B1
6702843 Brown Mar 2004 B1
6709379 Brandau et al. Mar 2004 B1
6709440 Callol et al. Mar 2004 B2
6712827 Ellis et al. Mar 2004 B2
6712845 Hossainy Mar 2004 B2
6723071 Gerdts et al. Apr 2004 B2
6736842 Healy et al. May 2004 B2
6743219 Dwyer et al. Jun 2004 B1
6743251 Eder Jun 2004 B1
6761734 Suhr Jul 2004 B2
6776771 van Moorlegem et al. Aug 2004 B2
6778316 Halas et al. Aug 2004 B2
6790227 Burgermeister Sep 2004 B2
6800065 Duane et al. Oct 2004 B2
6825203 Pasternak et al. Nov 2004 B2
6837901 Rabkin et al. Jan 2005 B2
6849084 Rabkin et al. Feb 2005 B2
6852252 Halas et al. Feb 2005 B2
6855125 Shanley Feb 2005 B2
6858034 Hijlkema et al. Feb 2005 B1
6878161 Lenker Apr 2005 B2
6884257 Cox Apr 2005 B1
6893417 Gribbons et al. May 2005 B2
6896695 Mueller et al. May 2005 B2
6899728 Phillips et al. May 2005 B1
6908624 Hossainy et al. Jun 2005 B2
6913619 Brown et al. Jul 2005 B2
6918928 Wolinsky et al. Jul 2005 B2
6939376 Shulz et al. Sep 2005 B2
6945989 Betelia et al. Sep 2005 B1
6945995 Nicholas Sep 2005 B2
6951053 Padilla et al. Oct 2005 B2
6962603 Brown et al. Nov 2005 B1
6964676 Gerberding et al. Nov 2005 B1
6991646 Clerc et al. Jan 2006 B2
6994721 Israel Feb 2006 B2
7004964 Thompson et al. Feb 2006 B2
7005454 Brocchini et al. Feb 2006 B2
7022132 Kocur Apr 2006 B2
7029493 Majercak et al. Apr 2006 B2
7037327 Salmon et al. May 2006 B2
7090694 Morris et al. Aug 2006 B1
7101840 Brocchini et al. Sep 2006 B2
7131993 Gregorich Nov 2006 B2
7137993 Acosta et al. Nov 2006 B2
7141063 White et al. Nov 2006 B2
7147655 Chermoni Dec 2006 B2
7147656 Andreas et al. Dec 2006 B2
7169172 Levine et al. Jan 2007 B2
7169174 Fischell et al. Jan 2007 B2
7172620 Gilson Feb 2007 B2
7175654 Bonsignore et al. Feb 2007 B2
7182779 Acosta et al. Feb 2007 B2
7192440 Andreas et al. Mar 2007 B2
7208001 Coyle et al. Apr 2007 B2
7208002 Shelso Apr 2007 B2
7220755 Betts et al. May 2007 B2
7223283 Chouinard May 2007 B2
7238197 Sequin et al. Jul 2007 B2
7241308 Andreas et al. Jul 2007 B2
7244336 Fischer et al. Jul 2007 B2
7270668 Andreas et al. Sep 2007 B2
7294146 Chew et al. Nov 2007 B2
7300456 Andreas et al. Nov 2007 B2
7309350 Landreville et al. Dec 2007 B2
7314480 Eidenschink et al. Jan 2008 B2
7320702 Hammersmark et al. Jan 2008 B2
7323006 Andreas et al. Jan 2008 B2
7326236 Andreas et al. Feb 2008 B2
7351255 Andreas Apr 2008 B2
7402168 Sanderson et al. Jul 2008 B2
7534449 Saltzman et al. May 2009 B2
7699886 Sugimoto Apr 2010 B2
7824439 Toyokawa Nov 2010 B2
7892273 George et al. Feb 2011 B2
7892274 Will et al. Feb 2011 B2
7905913 Chew et al. Mar 2011 B2
7918881 Andreas et al. Apr 2011 B2
7922755 Acosta et al. Apr 2011 B2
7938851 Olson et al. May 2011 B2
7938852 Andreas et al. May 2011 B2
7993388 Lee et al. Aug 2011 B2
8016870 Chew et al. Sep 2011 B2
8070789 Will et al. Dec 2011 B2
8070794 Issenmann Dec 2011 B2
8157851 Andreas Apr 2012 B2
8257427 Andersen et al. Sep 2012 B2
8282680 Kao et al. Oct 2012 B2
8317850 Kusleika Nov 2012 B2
8317859 Snow et al. Nov 2012 B2
8460358 Andreas et al. Jun 2013 B2
8486132 Snow et al. Jul 2013 B2
8585747 Andreas et al. Nov 2013 B2
8702781 Acosta et al. Apr 2014 B2
8740968 Kao et al. Jun 2014 B2
20010001824 Wu May 2001 A1
20010020154 Bigus et al. Sep 2001 A1
20010020173 Klumb et al. Sep 2001 A1
20010020181 Layne Sep 2001 A1
20010035902 Iddan et al. Nov 2001 A1
20010044595 Reydel et al. Nov 2001 A1
20010044632 Daniel et al. Nov 2001 A1
20010049547 Moore Dec 2001 A1
20010049549 Boylan et al. Dec 2001 A1
20020007212 Brown et al. Jan 2002 A1
20020032457 Sirhan et al. Mar 2002 A1
20020035395 Sugimoto Mar 2002 A1
20020037358 Barry et al. Mar 2002 A1
20020045914 Roberts et al. Apr 2002 A1
20020052642 Cox et al. May 2002 A1
20020087186 Shelso Jul 2002 A1
20020091439 Baker et al. Jul 2002 A1
20020092536 LaFontaine et al. Jul 2002 A1
20020107560 Richter Aug 2002 A1
20020111671 Stenzel Aug 2002 A1
20020123786 Gittings et al. Sep 2002 A1
20020123792 Burgermeister Sep 2002 A1
20020128706 Osypka Sep 2002 A1
20020138132 Brown Sep 2002 A1
20020151924 Shiber Oct 2002 A1
20020151955 Tran et al. Oct 2002 A1
20020156496 Chermoni Oct 2002 A1
20020165599 Nasralla Nov 2002 A1
20020168317 Daighighian et al. Nov 2002 A1
20020177890 Lenker Nov 2002 A1
20020183763 Callol et al. Dec 2002 A1
20020188343 Mathis Dec 2002 A1
20020188347 Mathis Dec 2002 A1
20020193873 Brucker et al. Dec 2002 A1
20030013266 Fukuda et al. Jan 2003 A1
20030045923 Bashiri et al. Mar 2003 A1
20030093143 Zhao et al. May 2003 A1
20030097169 Brucker et al. May 2003 A1
20030105511 Welsh et al. Jun 2003 A1
20030114912 Sequin et al. Jun 2003 A1
20030114919 McQuiston et al. Jun 2003 A1
20030114922 Iwasaka et al. Jun 2003 A1
20030125791 Sequin et al. Jul 2003 A1
20030125800 Shulze et al. Jul 2003 A1
20030125802 Callol et al. Jul 2003 A1
20030135259 Simso Jul 2003 A1
20030135266 Chew et al. Jul 2003 A1
20030139796 Sequin et al. Jul 2003 A1
20030139797 Johnson et al. Jul 2003 A1
20030139798 Brown et al. Jul 2003 A1
20030163085 Tanner et al. Aug 2003 A1
20030163155 Haverkost et al. Aug 2003 A1
20030176909 Kusleika Sep 2003 A1
20030191516 Weldon et al. Oct 2003 A1
20030195609 Berenstein Oct 2003 A1
20030199821 Gerdts et al. Oct 2003 A1
20030204238 Tedeschi Oct 2003 A1
20030208223 Kleiner Nov 2003 A1
20030212447 Euteneuer et al. Nov 2003 A1
20030225446 Hartley Dec 2003 A1
20040015224 Armstrong et al. Jan 2004 A1
20040024450 Shulze et al. Feb 2004 A1
20040030380 Shulze et al. Feb 2004 A1
20040044395 Nelson Mar 2004 A1
20040047909 Ragheb et al. Mar 2004 A1
20040073290 Chouinard Apr 2004 A1
20040087965 Levine et al. May 2004 A1
20040088044 Brown et al. May 2004 A1
20040093061 Acosta et al. May 2004 A1
20040093067 Israel May 2004 A1
20040093077 White et al. May 2004 A1
20040098081 Landreville et al. May 2004 A1
20040106979 Goicoechea Jun 2004 A1
20040111145 Serino et al. Jun 2004 A1
20040117008 Wnendt et al. Jun 2004 A1
20040138737 Davidson et al. Jul 2004 A1
20040143322 Litvack et al. Jul 2004 A1
20040176832 Hartley et al. Sep 2004 A1
20040181239 Dorn et al. Sep 2004 A1
20040186551 Kao et al. Sep 2004 A1
20040193245 Deem et al. Sep 2004 A1
20040215165 Coyle et al. Oct 2004 A1
20040215312 Andreas et al. Oct 2004 A1
20040215331 Chew et al. Oct 2004 A1
20040230285 Gifford, III et al. Nov 2004 A1
20040243217 Andersen et al. Dec 2004 A1
20040249434 Andreas et al. Dec 2004 A1
20040249435 Andreas et al. Dec 2004 A1
20040249439 Richter et al. Dec 2004 A1
20050004657 Burgermeister Jan 2005 A1
20050010276 Acosta et al. Jan 2005 A1
20050038494 Eidenschink Feb 2005 A1
20050038505 Shulze et al. Feb 2005 A1
20050049673 Andreas et al. Mar 2005 A1
20050055077 Marco et al. Mar 2005 A1
20050075716 Yan Apr 2005 A1
20050080474 Andreas et al. Apr 2005 A1
20050080475 Andreas et al. Apr 2005 A1
20050085897 Bonsignore Apr 2005 A1
20050090846 Pedersen et al. Apr 2005 A1
20050101624 Betts et al. May 2005 A1
20050123451 Nomura Jun 2005 A1
20050125051 Eidenschink et al. Jun 2005 A1
20050131008 Betts et al. Jun 2005 A1
20050133164 Fischer et al. Jun 2005 A1
20050137622 Griffin Jun 2005 A1
20050143827 Globerman et al. Jun 2005 A1
20050149159 Andreas et al. Jul 2005 A1
20050149168 Gregorich Jul 2005 A1
20050165378 Heinrich et al. Jul 2005 A1
20050171568 Duffy Aug 2005 A1
20050182477 White Aug 2005 A1
20050209674 Kutscher et al. Sep 2005 A1
20050209676 Kusleika Sep 2005 A1
20050209680 Gale et al. Sep 2005 A1
20050222671 Schaeffer et al. Oct 2005 A1
20050228477 Grainger et al. Oct 2005 A1
20050245637 Hossainy et al. Nov 2005 A1
20050249777 Michal et al. Nov 2005 A1
20050278011 Peckham Dec 2005 A1
20050288763 Andreas et al. Dec 2005 A1
20050288764 Snow et al. Dec 2005 A1
20050288766 Plain et al. Dec 2005 A1
20060069424 Acosta et al. Mar 2006 A1
20060173529 Blank Aug 2006 A1
20060177476 Saffran Aug 2006 A1
20060200223 Andreas et al. Sep 2006 A1
20060206190 Chermoni Sep 2006 A1
20060229700 Acosta et al. Oct 2006 A1
20060229706 Shulze et al. Oct 2006 A1
20060271150 Andreas et al. Nov 2006 A1
20060271151 McGarry et al. Nov 2006 A1
20060282147 Andreas et al. Dec 2006 A1
20060282149 Kao Dec 2006 A1
20060282150 Olson et al. Dec 2006 A1
20060287726 Segal et al. Dec 2006 A1
20070010869 Sano Jan 2007 A1
20070027521 Andreas et al. Feb 2007 A1
20070043419 Nikolchev et al. Feb 2007 A1
20070067012 George et al. Mar 2007 A1
20070088368 Acosta et al. Apr 2007 A1
20070088420 Andreas et al. Apr 2007 A1
20070088422 Chew et al. Apr 2007 A1
20070100423 Acosta et al. May 2007 A1
20070100424 Chew et al. May 2007 A1
20070106365 Andreas et al. May 2007 A1
20070118202 Chermoni May 2007 A1
20070118203 Chermoni May 2007 A1
20070118204 Chermoni May 2007 A1
20070129733 Will et al. Jun 2007 A1
20070135906 Badylak et al. Jun 2007 A1
20070156225 George et al. Jul 2007 A1
20070156226 Chew et al. Jul 2007 A1
20070179587 Acosta et al. Aug 2007 A1
20070219612 Andreas et al. Sep 2007 A1
20070219613 Kao et al. Sep 2007 A1
20070265637 Andreas et al. Nov 2007 A1
20070270936 Andreas et al. Nov 2007 A1
20070276461 Andreas et al. Nov 2007 A1
20070281117 Kaplan et al. Dec 2007 A1
20070292518 Ludwig Dec 2007 A1
20080004690 Robaina Jan 2008 A1
20080046067 Toyokawa Feb 2008 A1
20080071345 Hammersmark et al. Mar 2008 A1
20080077229 Andreas et al. Mar 2008 A1
20080091257 Andreas et al. Apr 2008 A1
20080097574 Andreas et al. Apr 2008 A1
20080125850 Andreas et al. May 2008 A1
20080132989 Snow et al. Jun 2008 A1
20080147162 Andreas et al. Jun 2008 A1
20080177369 Will et al. Jul 2008 A1
20080199510 Ruane et al. Aug 2008 A1
20080208311 Kao et al. Aug 2008 A1
20080208318 Kao et al. Aug 2008 A1
20080234795 Snow et al. Sep 2008 A1
20080234798 Chew et al. Sep 2008 A1
20080234799 Acosta et al. Sep 2008 A1
20080243225 Satasiya et al. Oct 2008 A1
20080249607 Webster et al. Oct 2008 A1
20080269865 Snow et al. Oct 2008 A1
20090076584 Mao et al. Mar 2009 A1
20090088832 Chew et al. Apr 2009 A1
20090105686 Snow et al. Apr 2009 A1
20090149863 Andreas et al. Jun 2009 A1
20090234428 Snow et al. Sep 2009 A1
20090248137 Andersen et al. Oct 2009 A1
20090248140 Gerberding Oct 2009 A1
20090264979 Kao et al. Oct 2009 A1
20090276030 Kusleika Nov 2009 A1
20100004729 Chew et al. Jan 2010 A1
20110022148 Ruane et al. Jan 2011 A1
20110093056 Kaplan et al. Apr 2011 A1
20110125248 George et al. May 2011 A1
20110152996 Snow et al. Jun 2011 A1
20130060321 Kao et al. Mar 2013 A1
20130211494 Snow et al. Aug 2013 A1
20140018899 Snow et al. Jan 2014 A1
20140188205 Andreas et al. Jul 2014 A1
20140228931 Acosta et al. Aug 2014 A1
20140236282 Andreas et al. Aug 2014 A1
Foreign Referenced Citations (90)
Number Date Country
1856280 Nov 2006 CN
1 953 1659 Mar 1997 DE
1 963 0469 Jan 1998 DE
199 50 756 Aug 2000 DE
101 03 000 Aug 2002 DE
0 203 945 Dec 1986 EP
0 274 129 Jul 1988 EP
0 282 143 Sep 1988 EP
0 364 787 Apr 1990 EP
0 505 686 Sep 1992 EP
0 533 960 Mar 1993 EP
0 696 447 Feb 1996 EP
0 714 640 Jun 1996 EP
0 797 963 Jan 1997 EP
0 596 145 May 1997 EP
0 947 180 Oct 1999 EP
1 254 644 Nov 2002 EP
1 258 230 Nov 2002 EP
1 266 638 Dec 2002 EP
1 277 449 Jan 2003 EP
1 290 987 Mar 2003 EP
1 318 765 Jun 2003 EP
1 470 834 Oct 2004 EP
1 523 959 Apr 2005 EP
1 523 960 Apr 2005 EP
1 743 603 Jan 2007 EP
2277875 Nov 1994 GB
03-133446 Jun 1991 JP
07-132147 May 1995 JP
10-503663 Apr 1998 JP
10-295823 Nov 1998 JP
11-503056 Mar 1999 JP
2935561 Aug 1999 JP
2001-190687 Jul 2001 JP
2002-538932 Nov 2002 JP
2004-121343 Apr 2004 JP
9427667 Dec 1994 WO
9526695 Oct 1995 WO
WO 9529647 Nov 1995 WO
WO 9626689 Sep 1996 WO
WO 9633677 Oct 1996 WO
9637167 Nov 1996 WO
9639077 Dec 1996 WO
9710778 Mar 1997 WO
WO 9746174 Dec 1997 WO
WO 9748351 Dec 1997 WO
WO 9820810 May 1998 WO
WO 9837833 Sep 1998 WO
WO 9858600 Dec 1998 WO
WO 9901087 Jan 1999 WO
9965421 Dec 1999 WO
WO 0012832 Mar 2000 WO
WO 0015151 Mar 2000 WO
WO 0025841 May 2000 WO
WO 0032136 Jun 2000 WO
WO 0041649 Jul 2000 WO
WO 0050116 Aug 2000 WO
0051525 Sep 2000 WO
0056237 Sep 2000 WO
WO 0062708 Oct 2000 WO
WO 0072780 Dec 2000 WO
0126707 Apr 2001 WO
0134063 May 2001 WO
WO 0170297 Sep 2001 WO
WO 0191918 Dec 2001 WO
02060344 Aug 2002 WO
02071975 Sep 2002 WO
WO 02085253 Oct 2002 WO
02098326 Dec 2002 WO
WO 03022178 Mar 2003 WO
WO 03047651 Jun 2003 WO
WO 03051425 Jun 2003 WO
WO 03075797 Sep 2003 WO
WO 2004017865 Mar 2004 WO
WO 2004043299 May 2004 WO
WO 2004043301 May 2004 WO
WO 2004043510 May 2004 WO
WO 2004052237 Jun 2004 WO
2004087006 Oct 2004 WO
2004091441 Oct 2004 WO
WO 2005009295 Feb 2005 WO
WO 2005013853 Feb 2005 WO
2005023153 Mar 2005 WO
WO 2006036939 Apr 2006 WO
WO 2006047520 May 2006 WO
WO 2007035805 Mar 2007 WO
WO 2007053187 May 2007 WO
WO 2007146411 Dec 2007 WO
WO 2008005111 Jan 2008 WO
20090111203 Sep 2009 WO
Non-Patent Literature Citations (53)
Entry
International Search Report and Written Opinion of PCT Application No. PCT/US2009/034889, dated Apr. 22, 2009, 13 pages total.
“Drug Delivery Stent With Holes Located on Neutral Axis” Research Disclosure, Kenneth Mason Publications, Hampshire, CB, No. 429, Jan. 2000, p. 13, XP00976354.
Chu et al., “Preparation of Thermo-Responsive Core-Shell Microcapsules with a Porous Membrane and Poly(N-isopropylacrylamide) Gates,” J Membrane Sci, Oct. 15, 2001; 192(1-2):27-39.
Tilley , “Biolimus A9-Eluting Stent Shows Promise,” Medscape Medical News, Oct. 5, 2004; retrieved from the internet: <http://www.medscape.com/viewarticle/490621>, 2 pages total.
Weir et al., “Degradation of poly-L-lactide. Part 2: increased temperature accelerated degradation,” Proc Inst Mech Eng H. 2004;218(5):321-30.
Extended European Search Report of corresponding European Application No. 09717057.5, dated Feb. 15, 2013. 5 pages.
Supplementary European Search Report of EP Patent Application No. 07758831, dated Dec. 14, 2009.
International Search Report and Written Opinion of PCT Application No. PCT/US2007/086864, mailed May 13, 2008, 13 pages total.
Supplementary European Search Report of EP Patent Application No. 02804509, dated Dec. 13, 2006, 2 pages total.
Supplementary European Search Report of EP Patent Application No. 04749567, dated Sep. 11, 2006, 2 pages total.
International Search Report and Written Opinion of PCT Application No. PCT/US2008/061041, mailed Nov. 7, 2008, 13 pages total.
The State Intellectual Property Office of the Republic of China, Application No. 200880100150.2, First Office Action date of dispatch Oct. 26, 2011, 11 pages.
The State Intellectual Property Office of the People's Republic of China, Application No. 200880100150.2, Second Office Action date of dispatch Jul. 25, 2012, 23 pages.
Office Action of Japanese Patent Application No. 2006-547139, mailed Jun. 15, 2010, 5 pages total. (English translation included).
The State Intellectual Property Office of the People's Republic of China, 200880100150.2, Third Office Action date of dispatch Apr. 12, 2013, 26 pages.
Colombo, “The Invatec Bifurcation Stent Solution” Bifurcation Stents: Novel Solutions, TCT 2003, Washington: Sep. 15-19, 2003, 24 pages total.
Cooley et al., “Applications of Ink-Jet Printing Technology to BioMEMs and Microfluidic Systems,” Proceedings, SPIE Conference on Microfludics and BioMEMs, (Oct. 2001).
Evans Analytical Group, “Functional Sites on Non-polymeric Materials: Gas Plasma Treatment and Surface Analysis,” http://www.eaglabs.com.
Joung et al., “Estrogen Release from metallic Stent Surface for the Prevention of Restenosis,” Journal of Controlled Release 92 (2003) pp. 83-91.
Lefevre et al. “Approach to Coronary Bifurcation Stenting in 2003,” Euro PCR, (May 2003) 28 pages total.
“STENT”. Definitions from Dictionary.com. Unabridged 9v1.01). Retrieved Sep. 22, 2006, from Dictionary.com website: <http://dictionary.reference.com/search?q=stent>.
Stimpson et al., Parallel Production of Oligonucleotide Arrays using Membranes and Reagent Jet Printing, BioTechniques 25:886-890 (Nov. 1998).
Supplementary European Search Report of EP patent Application No. 05727731.1, dated Mar. 25, 2008, 2 pages total.
Supplementary European Search Report of EP Patent Application No. 05744136, dated Mar. 26, 2008, 3 pages total.
U.S. Appl. No. 60/336,607, filed Dec. 3, 2001, first names inventor: Bernard Andreas.
U.S. Appl. No. 60/336,767, filed Dec. 3, 2001, first named inventor: Bernard Andreas.
U.S. Appl. No. 60/336,967, filed Dec. 3, 2001, first named inventor: Sunmi Chew.
U.S. Appl. No. 60/364,389, filed Mar. 13, 2002, first named inventor: Sunmi Chew.
U.S. Appl. No. 60/440,839, filed Jan. 17, 2003, first named inventor: Bernard Andreas.
U.S. Appl. No. 60/561,041, filed Apr. 9, 2004, first named inventor: Jeffry Grainger.
U.S. Appl. No. 60/784,309, filed Mar. 20, 2006, first named inventor: Bernard Andreas.
U.S. Appl. No. 60/810,522, filed Jun. 2, 2006, first named inventor: Stephen Kaplan.
U.S. Appl. No. 60/890,703, filed Feb. 20, 2007, first named inventor: Patrick Ruane.
U.S. Appl. No. 61/012,317, filed Dec. 7, 2007, first named inventor: Patrick Ruane.
U.S. Appl. No. 09/097,855, filed Jun. 15, 1998, first named inventor: Enrique J. Klein; Abandoned.
U.S. Appl. No. 09/225,364, filed Jan. 4, 1999, first named inventor: Aaron V. Kaplan; abandoned.
U.S. Appl. No. 10/874,859, filed Jun. 22, 2004, first named inventor: Pablo Acosta. Abandoned.
U.S. Appl. No. 11/462,951, filed Aug. 7, 2006, first named inventor: David Snow.
U.S. Appl. No. 11/627,096, filed Jan. 25, 2007, first named inventor: Bernard Andreas.
U.S. Appl. No. 11/689,927, filed Mar. 22, 2007, first named inventor: David Snow.
U.S. Appl. No. 11/752,448, filed May 23, 2007, first named inventor: David Snow.
U.S. Appl. No. 11/771,929, filed Jun. 29, 2007, first named inventor: David Snow.
U.S. Appl. No. 11/857,562, filed Sep. 19, 2007, first named inventor: Bryan Mao.
U.S. Appl. No. 11/938,730, filed Nov. 12, 2007, first named inventor: Sunmi Chew.
U.S. Appl. No. 11/945,142, filed Nov. 26, 2007, first named inventor: Bernard Andreas.
U.S. Appl. No. 11/947,677, filed Nov. 29, 2007, first named inventor: Dan Hammersmark.
U.S. Appl. No. 11/952,644, filed Dec. 7, 2007, first named inventor: Bernard Andreas.
U.S. Appl. No. 12/033,586, filed Feb. 19, 2008, first named inventor: Patrick H. Ruane.
U.S. Appl. No. 12/040,598, filed Feb. 29, 2008, first named inventor: Bernard Andreas.
U.S. Appl. No. 12/061,951, filed Apr. 3, 2008, first named inventor: Stephen Kao.
U.S. Appl. No. 12/109,477, filed Apr. 25, 2008, first named inventor: Stephen Kao.
U.S. Appl. No. 12/127,147, filed May 27, 2008, first named inventor: Sunmi Chew.
U.S. Appl. No. 12/133,909, filed Jun. 5, 2008, first named inventor: David Sanderson.
Related Publications (1)
Number Date Country
20090228088 A1 Sep 2009 US